Henagliflozin (SHR3824) is a potent selective sodium-glucose co-transporter 2 ( SGLT2 ) inhibitor with the IC 50 values of 2.38 and 4324 nM for human SGLT2 and SGLT1 , respectively. Henagliflozin can be used in diabetes research.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.